glp-1 drugs in development Agonists Weight Loss Market Report, 2025-2030 Emerging Trends in the Development
Description
It is a single molecule that acts as a triple agonist for GLP-1, GIP, and glucagon receptors
Researchers found that GLP-1 signaling directly correlated with the decrease of pro-inflammatory cytokine production, which includes tumor necrosis factor-alpha (TNF-) and interleukin-6 (IL-6)
The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript
doi: 10.1681/ASN.2013101067
2021;270 doi: 10.1016/j.lfs.2020.118966
Galician Med J
